Health
Studies Find B7-H3 Protein a Novel, Promising Target for Prostate Cancer Treatments – Newswise
The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers,…
Newswise — The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center. The studies were presented…
Continue Reading
-
Noosa News15 hours agoFull house as Minister shares vision for Sunshine Coast transport
-
Business13 hours agoWhy I’d buy these top ASX 200 shares next
-
Business10 hours ago10 reasons to buy and hold this tech stock forever
-
General15 hours agoWill AI solve our productivity problem or increase unemployment?